Roche has 60.4% of Spark, plans to wrap up takeover on Tuesday

Swiss drugmaker Roche Holding plans to complete on Tuesday its $4.3 billion takeover of Spark Therapeutics, it said, after winning U.S. regulatory approval for the long-delayed deal.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.